LifeMD, Inc. (LFMD)

From the record

LifeMD, Inc.'s filings since 2017 show 12 warning events of 2 kinds: an auditor change (8-K item 4.01, 6 times, the latest 2025-08-21); a late-report notice (Form NT 10-K or NT 10-Q, 6 times, the latest 2026-11-09) (its current reports).

From the record

LifeMD, Inc.'s 8 filed years say what it did: revenue went from $43 thousand in fiscal 2018 to $194 million in fiscal 2025, up 233.2% a year; it rose in 7 of 7 years; it never fell from a peak; net income was positive in 1 of 8 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, LifeMD, Inc.'s diluted share count grew about 13.4% a year, and dividends and buybacks returned about 28% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 1 sale and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, LifeMD, Inc. earned about 62 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 236 cents per dollar of everything the company owns. Leverage: it owed about 67 cents per dollar of assets, and net share issuance: its share count grew 9.5% over the year (the filed statements).

From the record

LifeMD, Inc.'s standing among 9 graded names in its industry family: revenue of $194 million in fiscal 2025 ranks in the bottom 42% by size; a net margin of 7.4% ranks in the top 17%; revenue growth of 17.7% a year over the last 3 filed years ranks in the top 39% (its annual reports).

From the record

LifeMD, Inc.'s leadership, from its insiders' filings and its current reports: no one files under a chief executive's title, so that part is not read; the 16 officers and directors filing in the last fifteen months have been on the record a median of 5.1 years (top 12%); 8 officer or director changes were reported on Form 8-K since 2023-11-13, against the 16 people in charge now (top 10%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

LifeMD, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $37 million against no long-term debt tagged leaves 52.2% of its assets as net cash, top 6% of its family; cash from operations less capital spending is 3.3% of revenue (top 39%); a gross margin of 85.7% (top 10%) (its annual report).

From the record

LifeMD, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 17.7% a year over the last three filed years against 233.2% over all 8, slowing (bottom 6% of its family); the newest year grew 25.4% (top 31%); capital spending grew 72.1% a year (top 19%) (its annual reports). LifeMD, Inc. reported 4 lines of business in fiscal 2024: Telehealth at $83 million, Telehealth Subscription Revenue at $70 million, Work Simpli at $54 million, and 1 more. 1 of 4 grew in the latest filed year, and the largest line is 39% of revenue (its annual report).

From the record

LifeMD, Inc.'s newest year against its own record: revenue of $194 million in fiscal 2025 came in 9.9% above the $177 million its prior three years' pace pointed to (top 25% of its family); net income of $14 million against a prior three-year average of $29 million (top 25%); a net margin of 7.4% against -21.9% before (top 42%) (its annual reports).